George N. Ioannou – 22 December 2016 – Transplant‐related survival benefit is calculated as the difference between life expectancy with transplantation and life expectancy without transplantation.
Paolo Cantù, Ilaria Parzanese, Valerio Balassone, Antonio Sario, Fiammetta Soggiu, Giovanni Lombardi, Federico Barbaro, Antonio Pisani, Anna Baldan, Giulio Cariani, Valentina Boarino, Alberto Fasoli, Helga Bertani, Edoardo Forti, Milutin Bulajic, Davide Ghinolfi, Elena Nadal, Angelo Cerofolini, Luca Barresi, Giorgia Catalano, Italo Stroppa, Sara Traini, Vincenzo Mazzaferro, Livio Cipolletta, Andrea Tringali, Guido Costamagna, Paolo Ravelli, Franco Bazzoli, Alberto Merighi, Maria Caterina Parodi, Rita Conigliaro, Massimiliano Mutignani, Maurizio Zilli, Franco Filipponi, Alberto Fantin, Luca
John G. O'Grady – 22 December 2016
Talia B. Baker – 22 December 2016
Paul D. Morris, Jerome M. Laurence, David Yeo, Michael Crawford, Simone I. Strasser, Geoffrey W. McCaughan, Charbel Sandroussi – 22 December 2016 – For a selected group of patients with hepatocellular carcinoma (HCC), liver transplantation (LT) represents the best chance of a cure. Organ shortages necessitate an efficient allocation of resources and careful prioritization on the transplantation waiting list.
Arpita Parmar, Shannon Marie Vandriel, Vicky Lee Ng – 22 December 2016 – With improved survival rates after pediatric liver transplantation (LT), attention is targeting improving the health‐related quality of life (HRQOL) as an outcome metric. We conducted a systematic review of the literature to examine HRQOL after pediatric LT, focusing on assessment tools and factors associated with HRQOL. A literature search was conducted through PubMed, Web of Science, Ovid, and Google Scholar for all studies matching the eligibility criteria between January 2004 and September 2016.
Henri Bismuth – 22 December 2016
Jens G. Brockmann, Thomas Vogel, Constantin Coussios, Peter J. Friend – 22 December 2016
Beatriz Revilla‐Nuin, África de Bejar, Laura Martínez‐Alarcón, José Ignacio Herrero, Carlos Manuel Martínez‐Cáceres, Pablo Ramírez, Alberto Baroja‐Mazo, José Antonio Pons – 22 December 2016 – Regulatory T cells (Tregs) play a potential role in operational tolerance in liver transplantation (LT) patients, and microRNAs (miRNAs) are known to be involved in immunological responses and tolerance.
Ahmad H. Ali, James H. Tabibian, Keith D. Lindor – 21 December 2016 – Cholestatic liver diseases are conditions with impaired bile formation and/or flow due to genetic, immunologic, environmental, or other causes. Unless successfully treated, this can lead to chronic liver injury and end‐stage liver disease. Primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) embody the most prominent adult cholestatic liver diseases with regard to incidence, morbidity, and mortality.